United Therapeutics (UTHR) Reports Submission of PMA to FDA for Medtronic's SynchroMed II Implantable DIS
Tweet Send to a Friend
United Therapeutics Corporation (Nasdaq: UTHR) announced that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
